NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study

The vesicular monoamine transporter 2: An underexplored pharmacological target

(2014) Alison I. Bernstein et al.   NEUROCHEMISTRY INTERNATIONAL

Evidence-based guideline: Treatment of tardive syndromes: Report of the Guideline Development Subcommittee of the American Academy of Neurology

(2013) R. Bhidayasiri et al.   NEUROLOGY

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

(2011) Kelly Posner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Tardive Dyskinesia

(2011) Pratibha G. Aia et al.   Current Treatment Options in Neurology

Incidence of Tardive Dyskinesia With Atypical Versus Conventional Antipsychotic Medications

(2010) Scott W. Woods et al.   JOURNAL OF CLINICAL PSYCHIATRY

Tardive dyskinesia and new antipsychotics

(2009) Christoph U Correll et al.   CURRENT OPINION IN PSYCHIATRY

Effects of Levetiracetam on Tardive Dyskinesia

(2009) Scott W. Woods et al.   JOURNAL OF CLINICAL PSYCHIATRY